CHARACTERISTICS OF ELECTROLYTE DISORDERS IN PATIENTS WITH ADRENALINE FAILURE CAUSED BY USE OF GLUCOCORTICOIDS
Main Article Content
Abstract
Objective: Describe the characteristics of electrolyte disturbances (Na+, K+ in blood) in patients with adrenal insufficiency due to glucocorticoid use at Bach Mai Hospital in 2024-2025. Subjects and methods: Cross-sectional, prospective descriptive study on 55 patients diagnosed with adrenal insufficiency with electrolyte disturbances due to GCs use at Bach Mai Hospital from December 2024 to June 2025. Results: Female/male sex ratio = 1/1,73. Average age is 64,87 years old. Type of Glucocorticoid drug used: Hydrocortisone (31,3%), other drugs (28,1% tablets), Methylprednisone (15,6%), Prednisone (14,1%), Dexamethasone (9,8%). Rate of patients: hyponatremia (62%), hyperkalemia (8%), hypokalemia (30%). In patients with hyponatremia: with clinical symptoms (59,5%), without clinical symptoms (40,5%). Average Na concentration: 125±8,9 mmol/l. In patients with hypokalemia: Average K concentration: 2,88±0.39 mmol/l, of which 33.3% of patients had ECG changes. In patients with hyperkalemia: Average K concentration: 5,46±0.33 mmol/l, with ECG changes in 20%. Conclusion: Electrolyte disorders in patients with adrenal insufficiency due to Glucocorticoids are common in men, often occurring in middle age, including hyponatremia, hypokalemia, hyperkalemia, mainly hyponatremia. The types of GCs used are diverse, but mainly concentrated and hydrocortisone. In patients with hyponatremia, most have clinical symptoms. In patients with hypokalemia, only a part recorded ECG changes. In contrast, in patients with hyperkalemia, ECG changes were noted predominantly.
Article Details
Keywords
Electrolyte disturbances; Glucocorticoid-induced adrenal insufficiency.
References
2. Ono Y, Ono S, Yasunaga H, Matsui H, Fushimi K, Tanaka Y. Clinical features and practice patterns of treatment for adrenal crisis: a nationwide cross-sectional study in Japan. Eur J Endocrinol. 2017;176(3):329-337. doi:10.1530/ EJE-16-0803
3. Sampieri G, Namavarian A, Lee JJW, Hamour AF, Lee JM. Hypothalamic-pituitary-adrenal axis suppression and intranasal corticosteroid use: A systematic review and meta-analysis. Int Forum Allergy Rhinol. 2022;12(1):11-27. doi:10.1002/alr.22863
4. Linh BNĐ. Suy thượng thận thứ phát ở người cao tuổi.
5. Aldosterone-independent regulation of the epithelial Na+ channel (ENaC) by vasopressin in adrenalectomized mice | PNAS. Accessed July 5, 2025. https://www. pnas.org/doi/10.1073/pnas.1201978109
6. Aldosterone-independent regulation of the epithelial Na+ channel (ENaC) by vasopressin in adrenalectomized mice | PNAS. Accessed July 5, 2025. https://www. pnas.org/doi/10.1073/pnas.1201978109
7. Chen S yu, Bhargava A, Mastroberardino L, et al. Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc Natl Acad Sci. 1999;96(5): 2514-2519. doi:10.1073/pnas. 96.5.2514
8. Nachawi N, Li D, Lansang MC. Glucocorticoid-induced adrenal insufficiency and glucocorticoid withdrawal syndrome: Two sides of the same coin. Cleve Clin J Med. 2024;91(4):245-255. doi:10.3949/ccjm.91a.23039
9. Kumar A, Ghosh M, Jacob JJ. Prevalence of adrenal insufficiency among patients with euvolemic hyponatremia. Endocr Connect. 2021;10(12):1623-1631. doi:10.1530/EC-21-0500
10. Borchers J, Mäkitie O, Jääskeläinen J, Laakso S. Recurrent Hypokalemia and Adrenal Steroids in Patients With APECED. Front Endocrinol. 2022;13: 904507. doi:10.3389/fendo. 2022.904507